What is the dosing for cefdinir (Cephalosporin antibiotic)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefdinir Dosing

Cefdinir is dosed at 14 mg/kg/day (maximum 600 mg/day) in pediatric patients aged 6 months through 12 years, administered either as 7 mg/kg every 12 hours or 14 mg/kg once daily, and 300 mg twice daily or 600 mg once daily in adults and adolescents, with treatment duration typically 5-10 days depending on the infection type. 1

Pediatric Dosing (6 Months Through 12 Years)

Standard Dosing:

  • Total daily dose: 14 mg/kg/day (maximum 600 mg/day) 1
  • Can be administered as:
    • 7 mg/kg every 12 hours, OR 1
    • 14 mg/kg once daily 1

Duration by Infection Type:

  • Acute bacterial otitis media: 5-10 days (once daily) or 10 days (twice daily) 1
  • Acute maxillary sinusitis: 10 days 1
  • Pharyngitis/tonsillitis: 5-10 days (once daily) or 10 days (twice daily) 1
  • Uncomplicated skin and skin structure infections: 10 days (twice daily only—once-daily dosing not studied for skin infections) 1

Weight-Based Dosing Chart (125 mg/5 mL suspension):

  • 9 kg (20 lbs): 2.5 mL every 12 hours or 5 mL once daily 1
  • 18 kg (40 lbs): 5 mL every 12 hours or 10 mL once daily 1
  • 27 kg (60 lbs): 7.5 mL every 12 hours or 15 mL once daily 1
  • 36 kg (80 lbs): 10 mL every 12 hours or 20 mL once daily 1
  • ≥43 kg (95 lbs): 12 mL every 12 hours or 24 mL once daily 1

Adult and Adolescent Dosing

Standard Dosing:

  • 300 mg twice daily, OR 1, 2
  • 600 mg once daily 1, 2
  • Treatment duration: 5-10 days depending on infection type 1, 2

Infection-Specific Guidance:

  • Cefdinir is listed as an alternative oral agent for beta-lactamase producing Haemophilus influenzae infections in community-acquired pneumonia 3
  • Effective for acute bacterial exacerbations of chronic bronchitis, community-acquired pneumonia, acute maxillary sinusitis, pharyngitis/tonsillitis, and uncomplicated skin infections 2, 4

Renal Dosing Adjustments

Adults with Creatinine Clearance <30 mL/min:

  • 300 mg once daily 1

Pediatric Patients with Creatinine Clearance <30 mL/min/1.73 m²:

  • 7 mg/kg (maximum 300 mg) once daily 1

Hemodialysis Patients:

  • Initial dose: 300 mg (or 7 mg/kg) every other day 1
  • At conclusion of each hemodialysis session: Give 300 mg (or 7 mg/kg) 1
  • Subsequent doses: 300 mg (or 7 mg/kg) every other day 1

Administration Considerations

Food Effects:

  • May be administered without regard to meals 1

Suspension Preparation:

  • After mixing, suspension can be stored at room temperature (25°C/77°F) 1
  • Container should be kept tightly closed and shaken well before each administration 1
  • Suspension may be used for 10 days, after which any unused portion must be discarded 1

Palatability:

  • Cefdinir oral suspension has demonstrated superior taste and palatability compared to other oral antimicrobial agents, which may improve adherence in pediatric patients 2, 4

Clinical Efficacy Context

Spectrum of Activity:

  • Good activity against Streptococcus pneumoniae (penicillin-susceptible), Haemophilus influenzae, and Moraxella catarrhalis 2, 4
  • Stable to hydrolysis by commonly occurring plasmid-mediated beta-lactamases 4
  • Retains activity against beta-lactamase-producing strains of H. influenzae and M. catarrhalis 4

Pharmacokinetics:

  • Peak plasma concentration occurs approximately 3 hours after oral administration 5
  • Terminal half-life approximately 1.5 hours 5
  • Distributes well into respiratory tract tissues, fluids, sinus tissue, tonsil tissue, middle ear fluid, and skin blisters 2, 4

Common Pitfalls

Skin Infection Dosing:

  • Once-daily dosing has NOT been studied for skin infections; therefore, cefdinir must be administered twice daily (7 mg/kg every 12 hours) for uncomplicated skin and skin structure infections 1

Diarrhea:

  • Diarrhea is the most common adverse event, occurring in approximately 20% of patients 6
  • While incidence may be higher than some comparators, discontinuation rates due to adverse events are generally similar 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.